Retail pharmacies must reinvent themselves to survive
Drug store consolidation leads to increased pressure on retail pharmacies -- and certain drug store chains will not survive
CVS Caremark Corp.’s acquisition of Longs Drug Stores Corp. illustrates the further consolidation of retail pharmacies, believes one industry expert.
“With managed care driving the growth of mail service pharmacy and specialty pharmacy there are fewer prescriptions for retail pharmacies,” Cohen says. “This leads to increased pressure on retail pharmacies, and certain drug store chains will not survive.”
Retail pharmacies are consolidating because of several issues:
• The impact of third-party payers, including Medicare, now on prescription drug reimbursement, which does not allow for chain pharmacies to operate stores that are not profitable.
• The need for retail pharmacists to reinvent themselves to add value in healthcare beyond drug distribution.
“This is a way for CVS to grow its revenue and increase its geographic footprint,” Perry says. “In addition, Longs Drugs is not big enough to go it on its own anymore.”
Megabrand CVS Caremark will buy Longs Drug Stores in a cash deal worth nearly $3 billion. Only the Longs Drugs locations in Hawaii will keep their old branding. Longs has 521 drugstores in California, Hawaii, Nevadaand Arizona and also operates Rx America, a PBM program that services more than 8 million members.
A Conversation With Greg Baker, RPh, CEO of AffirmedRx
March 31st 2024Greg Baker, CEO of AffirmedRx, describes his early career, shares some of his critical opinions about the pharmacy benefit management (PBM) industry and how, in his view, his company is offering a better alternative.
Read More
David Calabrese of OptumRx Talks New Role, Market Insulin Prices and Other Topics 'On His Mind'
April 13th 2023In this month’s episode of the "What's On Your Mind podcast," Peter Wehrwein, managing editor of MHE connects with the now Chief Clinical Officer of OptumRx Integrated Pharmacies, David Calabrese. In this conversation, David touches on his transition in January as OptumRx’s former chief pharmacy officer and market president of health plans and PBMs to his new role as Chief Clinical Officer where he now focuses more on things such as specialty pharmacy to home delivery — with an overall goal of creating whole-patient care. Throughout the conversation, Calabrese also touched on the market’s hot topic of insulin prices and behavioral health services within the OptumRx community, among other topics.
Listen
Florida Gets the OK. But Will Drug Importation from Canada Actually Happen?
March 5th 2024Canadian health officials warn that maintaining a drug supply for Canadians is their priority. The staunch opposition of the U.S. pharmaceutical industry may also be an obstacle to imports from north of the border.
Read More
Briana Contreras, editor of Managed Healthcare Executive, spoke with Nancy Lurker, CEO and president of EyePoint Pharmaceuticals. Nancy shared a bit about EyePoint and how the organization’s innovative therapies are addressing patient needs through eye care, and most importantly, she addressed C-Suite positions like the CEO role. Nancy shared advice for those seeking to reach the CEO level, especially toward women in healthcare and other roles, and what it takes to run a biopharma company.
Listen
What Payers Need to Know As Retail Pharmacies Move Into Primary Care
September 6th 2023Healthcare beyond the doors of the doctor’s office has the potential to offer more care to more people. But payers need to think about how to ensure that care is consistent. Regardless of the setting, care decisions must be based on evidence-based content and supported with strong patient education.
Read More
